Business & Finance
August market gains driven by software rebounds and promising vaccine data, Jim Cramer says
Several S&P 500 stocks recovered from earlier bearish trends to post significant gains on the month, propelled by positive business fundamentals and short squeezes.
The short version
- Moderna led the S&P 500's August winners with a 156% gain, boosted by positive results for an experimental melanoma vaccine developed with Merck.
- Enterprise software companies, including Palantir and Salesforce, rebounded sharply from previous lows as concerns over artificial intelligence disruption subsided.
- The software sector's upward momentum was further accelerated by the forced unwinding of a highly leveraged bearish hedge fund in late July.
Key facts
- Moderna posted a 156% gain in August, leading the S&P 500 after releasing promising results for its experimental mRNA melanoma vaccine.[CNBC]
- Several major enterprise software stocks experienced a significant monthly comeback, including Palantir (up 51.45%), Veeva Systems (up 40.2%), Salesforce (up 39.95%), and ServiceNow (up 33.05%).[CNBC]
- The software rebound was amplified by the forced liquidation of Situational Awareness, a highly leveraged hedge fund that had heavily shorted software stocks.[CNBC]
- Paramount Skydance rose 37.06% in August; market observer Jim Cramer noted that investors reacted positively to delays facing its proposed Warner Bros. Discovery acquisition.[CNBC]
- Super Micro Computer rose 31.27% and Sandisk gained 28.96%, supported by strong demand for memory technology used in AI data centers.[CNBC]
- Coinbase climbed 28.62% during the month, benefiting from a crypto rebound tied to investor concerns over U.S. government debt levels.[CNBC]
What remains uncertain
- The future of Paramount Skydance's proposed acquisition of Warner Bros. Discovery remains uncertain after California Attorney General Rob Bonta canceled a recent meeting, citing a lack of good faith in settlement talks.[CNBC]